Abstract: Methods for treating non-alcoholic steatohepatitis and/or hepatocellular carcinoma include administering a polypeptide antagonist of a Na/K ATPase/Src receptor complex to a subject in need thereof. Methods and assays for diagnosis or prognosis of non-alcoholic steatohepatitis and/or hepatocellular carcinoma in a subject are also provided and include the steps of providing a biological sample from the subject, determining an expression level or activity in the sample of at least one biomarker selected from Caveolin-1, Survivin, and SMAC; and comparing the expression level or activity of the at least one biomarker in the sample, if present, to a control expression level or activity of the at least one biomarker. Prophylaxis or treatment of the non-alcoholic steatohepatitis and/or hepatocellular carcinoma in a subject can then be initiated based on the expression level or activity of Caveolin-1, Survivin, and SMAC in the sample.

Abstract: Methods for treating non-alcoholic steatohepatitis and/or hepatocellular carcinoma include administering a polypeptide antagonist of a Na/K ATPase/Src receptor complex to a subject in need thereof. Methods and assays for diagnosis or prognosis of non-alcoholic steatohepatitis and/or hepatocellular carcinoma in a subject are also provided and include the steps of providing a biological sample from the subject, determining an expression level or activity in the sample of at least one biomarker selected from Caveolin-1, Survivin, and SMAC; and comparing the expression level or activity of the at least one biomarker in the sample, if present, to a control expression level or activity of the at least one biomarker. Prophylaxis or treatment of the non-alcoholic steatohepatitis and/or hepatocellular carcinoma in a subject can then be initiated based on the expression level or activity of Caveolin-1, Survivin, and SMAC in the sample.

Abstract: Ultra-low frequency (ULF) tactile stimuli, generated by an electro-mechanical actuator, have a spectrum of biological effects. These frequencies are herewith defined as 2 Hz or lower and may comprise stimulus frequencies as low as 0.1 Hz, or one cycle per ten seconds. The ULF generator can be paired with at least one sensor that is configured to monitor a physiological property of the user. A controller is in communication with the at least one electro-mechanical actuator and the at least one sensor and is configured to control operation of the at least one electro-mechanical actuator, in at least a first operating mode, based on measurements of the at least one sensor.

Abstract: Ultra-low frequency (ULF) tactile stimuli, generated by an electro-mechanical actuator, have a spectrum of biological effects. These frequencies are herewith defined as 2 Hz or lower and may comprise stimulus frequencies as low as 0.1 Hz, or one cycle per ten seconds. The ULF generator can be paired with at least one sensor that is configured to monitor a physiological property of the user. A controller is in communication with the at least one electro-mechanical actuator and the at least one sensor and is configured to control operation of the at least one electro-mechanical actuator, in at least a first operating mode, based on measurements of the at least one sensor.